|
30 Jul 2025 |
SRF
|
Consensus Share Price Target
|
3088.30 |
3080.07 |
- |
-0.27 |
hold
|
|
|
|
|
19 Jun 2024
|
SRF
|
Motilal Oswal
|
3088.30
|
2140.00
|
2416.75
(27.79%)
|
Target met |
Neutral
|
|
|
SRF witnessed a challenging year (revenue/EBITDA down ~12%/27% YoY), with multiple headwinds plaguing its business segments. The chemicals and packaging businesses inhibited SRF’s overall performance, while the technical textiles business remained flat. Due to this, the capex intensity also waned in FY24.
|
|
10 May 2024
|
SRF
|
IDBI Capital
|
3088.30
|
2658.00
|
2278.05
(35.57%)
|
Target met |
Buy
|
|
|
|
|
09 May 2024
|
SRF
|
Sharekhan
|
3088.30
|
2592.00
|
2291.35
(34.78%)
|
Target met |
Buy
|
|
|
Revenue for the quarter of Rs. 3570 crore was down 7% y-o-y and up 17% q-o-q. Chemical/ Technical textiles/packaging films segments grew 30%/8%/2% q-o-q and -14%/2%/9% y-o-y. Growth was affected due to the weak external environment in specialty chemicals and fluorochemicals.
|
|
09 May 2024
|
SRF
|
Prabhudas Lilladhar
|
3088.30
|
2123.00
|
2291.35
(34.78%)
|
Target met |
Sell
|
|
|
|
|
09 May 2024
|
SRF
|
Motilal Oswal
|
3088.30
|
2100.00
|
2291.35
(34.78%)
|
Target met |
Neutral
|
|
|
SRF reported another subdued operating performance in 4QFY24 with a significant decline in operating profitability (EBIT down 34% YoY), due to the continuing weakness in the Chemical/Packaging Film businesses (EBIT dipped 33%/19% YoY), which offset the strong performance in the Technical Textile business (EBIT jumped 44% YoY).
|
|
01 Feb 2024
|
SRF
|
IDBI Capital
|
3088.30
|
2770.00
|
2308.45
(33.78%)
|
Target met |
Buy
|
|
|
|
|
30 Nov 2023
|
SRF
|
IDBI Capital
|
3088.30
|
2913.00
|
2412.50
(28.01%)
|
|
Buy
|
|
|
|
|
31 Oct 2023
|
SRF
|
Edelweiss
|
3088.30
|
2530.00
|
2195.30
(40.68%)
|
Target met |
Buy
|
|
|
Weak H1, recovery expected in H2FY24
|
|
30 Oct 2023
|
SRF
|
Prabhudas Lilladhar
|
3088.30
|
2156.00
|
2181.40
(41.57%)
|
Target met |
Hold
|
|
|
|
|
30 Oct 2023
|
SRF
|
ICICI Securities Limited
|
3088.30
|
2100.00
|
2181.40
(41.57%)
|
Target met |
Hold
|
|
|
SRF’s Q2FY24 print for its chemical business (EBIT down 32.8% YoY) was below our expectations – hurt by lower sales in ref-gas and weakness in specialty sales from destocking. Despite this, SRF expects some growth in specialty chemicals revenue for FY24 and anticipates revival in ref-gas revenue in H2FY24E, as it has started to contract volumes in US for CY24 HFC quota.
|